SPRY
ARS Pharmaceuticals Kicks Off 2026 with Strong First Quarter Performance
ARS Pharmaceuticals, a commercial biopharmaceutical company focused on developing and commercializing innovative treatments, has made a promising start to 2026. The company's first quarter earnings conference call provided insight into its financial results and commercial highlights for the period. In the first quarter of 2026, ARS Pharmaceuticals generated